Churg-Strauss syndrome (CSS) in a patient receiving pranlukast

被引：12
|
作者：
Kobayashi, S [1 ]
Ishizuka, S [1 ]
Tamura, N [1 ]
Takaya, M [1 ]
Kaneda, K [1 ]
Hashimoto, H [1 ]
机构：
[1] Juntendo Univ, Sch Med, Dept Rheumatol & Internal Med, Bunkyo Ku, Tokyo 1138421, Japan
来源：
CLINICAL RHEUMATOLOGY | 2003年 / 22卷 / 06期
关键词：
Churg-Strauss syndrome; pranlukast;
D O I：
10.1007/s10067-003-0791-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pranlukast is a cysteinyl leukotriene receptor I antagonist (LTRAs) approved for treatment of asthma in Japan since 1995. Compared to other LTRAs, such as zafilukast and montelukast, only few cases with Churg-Strauss syndrome (CSS) have been reported in association with treatment with pranlukast. We describe a 17-year-old Japanese male patient who developed CSS with a 13 month history of mild asthma receiving pranlukast for 11 months without systemic and/or inhaled corticosteroid administration prior to development of CSS. From the aspect of temporal relationship between treatment with pranlukast and development of CSS, a direct induction of CSS by pranlukast is suggested in our case.
引用
收藏
页码：491 / 492
页数：2
相关论文
共 50 条
  • [1] Churg–Strauss syndrome (CSS) in a patient receiving pranlukast
    Shigeto Kobayashi
    Shyugo Ishizuka
    Naoto Tamura
    Makiyo Takaya
    Kazuhiko Kaneda
    Hiroshi Hashimoto
    [J]. Clinical Rheumatology, 2003, 22 : 491 - 492
  • [2] Churg-Strauss syndrome (CSS) in a patient with antiphospholipid syndrome (APS)
    Jackson, K
    Horiki, T
    Wakabayashi, T
    Yamada, C
    Hoshina, Y
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 54 - 54
  • [3] Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast
    Junsuke Shimbo
    Osamu Onodera
    Keiko Tanaka
    Shoji Tsuji
    [J]. Clinical Rheumatology, 2005, 24 : 661 - 662
  • [4] Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast
    Shimbo, J
    Onodera, O
    Tanaka, K
    Tsuji, S
    [J]. CLINICAL RHEUMATOLOGY, 2005, 24 (06) : 661 - 662
  • [5] Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS)
    Rosenberg, M
    Lorenz, HM
    Gassler, N
    Katus, HA
    Frey, N
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 (05) : 289 - 294
  • [6] Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast
    Kinoshita, M
    Shiraishi, T
    Koga, T
    Ayabe, M
    Rikimaru, T
    Oizumi, K
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (03) : 534 - 535
  • [7] Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma
    Hashimoto, M
    Fujishima, T
    Tanaka, H
    Kon, H
    Saikai, T
    Suzuki, A
    Nakatsugawa, M
    Abe, S
    [J]. INTERNAL MEDICINE, 2001, 40 (05) : 432 - 434
  • [8] A case of relapse of Churg-Strauss syndrome (CSS) with crescentic lesions
    Yoshikazu, F.
    [J]. PRESSE MEDICALE, 2013, 42 (04): : 696 - 696
  • [9] The Churg-Strauss syndrome after praniukast treatment in a patient not receiving corticosteroids
    Katsura, T
    Yoshida, F
    Takinishi, Y
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) : 386 - 387
  • [10] Management of Churg-Strauss Syndrome (CSS) in the setting of Disseminated Histoplasmosis
    Khalid, Haroon
    Hayat, Sadia
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB211 - AB211
12345